,ticker,comment,username,score,permalink,neg,neu,pos,compound
0,RH, Would be better to say: stop being at RH,SidMcDout,154,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gskjax6/,0.182,0.579,0.24,0.1779
1,ANY, Do you actually believe flipping a little switch in ANY app for that matter stops them from sharing your data??,ImpishFinch,46,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gskpwbv/,0.073,0.732,0.195,0.3939
2,RH, I couldn't even find this setting. Out of RH now but I legit looked before transferring my account.,niftyifty,2,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslfb7e/,0.0,1.0,0.0,0.0
3,RH," better yet, quit using RH",dacoobob,2,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslr8or/,0.0,0.58,0.42,0.4404
4,RH," Might as well go through all your apps like this too, don‚Äôt stop at RH",benji_tha_bear,5,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsl20cz/,0.117,0.638,0.245,0.34
5,TD," Every broker sells your data. I contacted TD Ameritrade and they told me i can turn that off. Everyone should turn it off. Also do everything in your power to stop the corruption. Dont use margins, turn off data sharing, tell your broker to track down your shares. 
   Im a fairly new investor. But anyone can clearly see that the market is rigged.",PokerSteve801,2,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslgg2d/,0.07,0.816,0.114,0.4588
6,RH," Or even better, stop using RH",Ronkiman,1,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsl6wzq/,0.242,0.44,0.319,0.1779
7,RH, RH is for bitches.,pdf_document,1,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslcw7x/,0.565,0.435,0.0,-0.5994
8,RH, I use Public now. RH can burn.,DeeDubbya11,0,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsl6tnz/,0.0,1.0,0.0,0.0
9,RH, Just get off RH,Gooderesterest,0,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsle6ew/,0.0,1.0,0.0,0.0
10,OR, OR STOP USING ROBINHOOD,PupPop,0,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslnbaw/,0.423,0.577,0.0,-0.296
11,RH, Trying to get out of RH as soon as my tanking stops,curaga12,-3,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsldlnn/,0.127,0.873,0.0,-0.1531
12,RH, Why is this here? There‚Äôs almost zero penny stocks on RH,GeoffKoch,0,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslx0ii/,0.0,1.0,0.0,0.0
13,RH, Lol just stop using RH OP,JonathanL73,0,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsm1v3x/,0.244,0.444,0.311,0.1531
14,TD, Webull and TD Ameritrade were in the same lawsuits as Robinhood.,Ok_Brilliant4181,26,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsksedw/,0.138,0.862,0.0,-0.1531
15,RH," Any company, RH, Webull, TD Ameritrade, etc all offer commission free trading....so if you don‚Äôt want to be the product, use a broker that charges a commission. What‚Äôs that? Don‚Äôt want to pay a commission? Well then I guess you are the product then...",Ok_Brilliant4181,10,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsksbdq/,0.076,0.741,0.182,0.594
16,TD," Any company, RH, Webull, TD Ameritrade, etc all offer commission free trading....so if you don‚Äôt want to be the product, use a broker that charges a commission. What‚Äôs that? Don‚Äôt want to pay a commission? Well then I guess you are the product then...",Ok_Brilliant4181,10,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsksbdq/,0.076,0.741,0.182,0.594
17,RH," This isn‚Äôt true anymore. RH charges a commission. Small, but it‚Äôs there at every trade.",rajshankara,1,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslfbu7/,0.1,0.777,0.123,0.09
18,TD, Hate to break it to you but TD Ameritrade uses PFOF too,ThrasherLA,21,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslkdmw/,0.176,0.824,0.0,-0.3291
19,TDA, TDA is under investigation? For what?,redspo,-23,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslk9dm/,0.0,1.0,0.0,0.0
20,TD, TD then learn how to use ToS effectively.,Mr_Twinkie-,1,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslnak1/,0.0,0.707,0.293,0.4404
21,TD, TD. Think or Swim ftw,cptwinklestein,4,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsl6oa7/,0.0,0.571,0.429,0.4588
22,RH, I think he‚Äôs referencing RH,TheBurntHam,2,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslnplk/,0.0,1.0,0.0,0.0
23,TD," Have Schwab and TD Ameritrade.

Schwab has higher fees than TD Ameritrade.",jbokwxguy,1,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslmxml/,0.0,1.0,0.0,0.0
24,TD," TD restricted buying, as well.",thankstrumpet,5,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslbzmy/,0.338,0.39,0.273,-0.128
25,MS," Agreed - multiple brokers is OK if you use them for different reasons.

I use Schwab for short term personal investments and penny stocks, Transamerica for my 401K and MS for lorn term personal investments, all based around fees and such",TheBurntHam,3,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslo6bs/,0.0,0.88,0.12,0.6166
26,RH, i‚Äôve split across brokers too but importantly not RH,FrankTheHead,1,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslj258/,0.0,0.731,0.269,0.4497
27,RH," RH, eToro, etc. are neither a bank nor a real broker. They are called trading platforms. 

The difference is that they are not fully under the rules like banks and brokers. 

Nearly each zero-commission platform is 

1. lending your shares and/or
2. Not buying the share you wanted to buy, instead they pay you the difference between buy and sell price. You never own a share. Just ask if you will be able to vote with your shares at shareholder meeting.   and/or
3. Selling your order flow to hedgefonds",SidMcDout,14,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslfnyo/,0.056,0.869,0.075,0.4067
28,TD, TD Ameritrade IS Schwab... They were bought so eventually there will be no differences between the two,bertrum2k,2,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslpgw7/,0.121,0.879,0.0,-0.296
29,RH, Only on margin. If you were buying cash you could buy as much as you want. TD only restricted as much as necessary to cover their own asses. They didn't do anything close to what RH did.,WhyBuyMe,3,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslelwo/,0.067,0.9,0.033,-0.3182
30,TD, Only on margin. If you were buying cash you could buy as much as you want. TD only restricted as much as necessary to cover their own asses. They didn't do anything close to what RH did.,WhyBuyMe,3,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gslelwo/,0.067,0.9,0.033,-0.3182
31,RH, I have been on RH for over a year. I like how simple it is but must admit they have done some shady stuff. I recently opened an E*TRADE acct to get an OTC stock and was shocked by the $6.95 fee.,Jeff-Skip,1,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsm0yn4/,0.07,0.835,0.094,0.0
32,UI," Fidelity is one of the best brokers you can use, the UI isnt clean, but Fidelity is great where it matters most, best price action, real customer support, no restrictions on buying meme stock.",JonathanL73,9,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsm24lx/,0.088,0.538,0.374,0.9462
33,TA, TradingView is also legit for charting and TA.,InvestfulApp,2,/r/pennystocks/comments/meyz9e/stop_robinhood_from_sharing_your_data/gsm0piy/,0.0,1.0,0.0,0.0
34,CTXR," I'm still holding HITIF, ZOM, CTXR, and PONGF.",Sirus_the_Cat,9,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsla2lh/,0.0,1.0,0.0,0.0
35,ZOM," I'm still holding HITIF, ZOM, CTXR, and PONGF.",Sirus_the_Cat,9,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsla2lh/,0.0,1.0,0.0,0.0
36,DD, Rlftf - if good news tomorrow am this should run hard - nice thing to know is results are premarket so you'll know right away if it's going to run or not - do your DD as I'm heavily biased,Puzzleheaded_Fan_123,3,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gskyhge/,0.083,0.782,0.135,0.4939
37,GL, Buying one last bit in $NSPX and waiting for the pop.  Short volume dropped off a cliff Friday (4% vs 40% on Thursday).  Feels like news is imminent.  Year end report is due 3/31/21.  GL.,adudereadingthings,3,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gskznq1/,0.0,0.853,0.147,0.6739
38,IP," Anyone else into IP - ImagineAR who partnered with liquidAR lately in the NFT space? I‚Äôve been holding for a while, it retraced almost 30% lately so curious if it‚Äôs on people‚Äôs radars?",alwaysadmiring,2,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsl7pp2/,0.0,0.9,0.1,0.5189
39,CSCW, CSCW anyone?,MrTinkle5,2,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsktveu/,0.0,1.0,0.0,0.0
40,ZOM, ZOM looking prime to rip. This is a good hold for 2-3 years in my opinion,Gooderesterest,2,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gslf5zh/,0.0,0.828,0.172,0.4404
41,AR," Adding more to my position in SANP while its cheap. Complete lottery play but the are working on an AR NFT based game.  CEO said he would release info in 2 weeks but gave a sneak preview on his reddit page.

If they can show they can get pink current by May like the CEO says and prove the aren‚Äôt a scam, it will moon.",kynewt,1,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gslgqhx/,0.073,0.855,0.072,-0.2732
42,DD, Too many people trying to pump up eeenf while completely disregarding an actual legit stock with a product and a legacy brand. I‚Äôm not going to do your work for you but I highly suggest to do your DD on number 8.,Bloodlust2424,1,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsls43v/,0.04,0.924,0.036,-0.0378
43,ASRT, where is ASRT at?,Educational_Ask497,1,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gslte8b/,0.0,1.0,0.0,0.0
44,DD, Most of the time DD on penny stocks seems to be a dead end.  Plan on unlevering and going more into individual stocks. More research and less buying plan on holding more cash for awhile,Dragon22wastaken,1,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsmb0lc/,0.115,0.885,0.0,-0.6486
45,DD, I did [this](https://www.reddit.com/r/pennystocks/comments/m68w93/i_analyze_mentions_and_sentiment_of_stocks_across/?utm_medium=android_app&utm_source=share) detailed DD on high tide. Hope you find it useful :),nobjos,5,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsl9meg/,0.0,0.532,0.468,0.8316
46,UAL,"  It's calculated using natural language processing with a modified version of vadersentiment. You get pre-trained models which classify whether a given statement is positive or negative. I have modified it to analyze financial comments also ( eg. Calls, puts, moon, gain, loss, etc). It then classifies the statement between -100% and +100% depending on if it's negative or positive respectively. The numbers you are seeing here are the average across all the comments.

[here](http://imgur.com/gallery/vyg92Nz) is a sample of the sentiment analysis I posted when Boeing's engine failed on UAL flight.",nobjos,2,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gslbmrs/,0.126,0.725,0.15,0.3612
47,DD," Thanks for your support - but i don't like that gut of yours .   That made me think though,  with all this investing I'm doing,  I should buy one of those magic 8 balls i had when i was a kid. That might be more reliable than my DD .",Efficient_Injury_829,3,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsl8bjq/,0.06,0.855,0.085,0.0348
48,GM," That‚Äôs totally fair. I think the industry as a whole is going to boom, so both will make you money (Except Redwood). I disagree however that LiCycle has more potential. 

ABML has a pending RFP, ‚ÄúDevelopment of a cell using recovered active materials from end of life vehicle Li-ion batteries‚Äù pending with GM and Ford to be released this upcoming quarter. 

ABML also has contracts with the worlds two largest chemical companies and has been working with DOT to secure deep water ports. LiCycle will make money, but ABML will make more IMO. No reason to not play both at ABML‚Äôs current price though :)",jab116,4,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsl71f7/,0.069,0.846,0.085,0.1962
49,IMO," That‚Äôs totally fair. I think the industry as a whole is going to boom, so both will make you money (Except Redwood). I disagree however that LiCycle has more potential. 

ABML has a pending RFP, ‚ÄúDevelopment of a cell using recovered active materials from end of life vehicle Li-ion batteries‚Äù pending with GM and Ford to be released this upcoming quarter. 

ABML also has contracts with the worlds two largest chemical companies and has been working with DOT to secure deep water ports. LiCycle will make money, but ABML will make more IMO. No reason to not play both at ABML‚Äôs current price though :)",jab116,4,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsl71f7/,0.069,0.846,0.085,0.1962
50,RFP," That‚Äôs totally fair. I think the industry as a whole is going to boom, so both will make you money (Except Redwood). I disagree however that LiCycle has more potential. 

ABML has a pending RFP, ‚ÄúDevelopment of a cell using recovered active materials from end of life vehicle Li-ion batteries‚Äù pending with GM and Ford to be released this upcoming quarter. 

ABML also has contracts with the worlds two largest chemical companies and has been working with DOT to secure deep water ports. LiCycle will make money, but ABML will make more IMO. No reason to not play both at ABML‚Äôs current price though :)",jab116,4,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsl71f7/,0.069,0.846,0.085,0.1962
51,ON, DD: Guess what? High Tide just opened a brand new location... ON THE MOON!,BlackChapel,1,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsmebh9/,0.0,1.0,0.0,0.0
52,USA," well then here you go!  

**DD**

**Core Product**

High Tide is Canada‚Äôs largest cannabis retailer. The company was founded in 2018 when Canada legalized cannabis. They are a pure-play retailer which allows them to bypass the Ontario govt‚Äôs limit on vertical integration.

They are one of the two front-runners in the Canadian cannabis retail industry. The company just completed Its merger with Meta Growth, to become the largest cannabis retailer in Canada. They also own Grasscity which is an Amsterdam-based global e-commerce site for smoking and cannabis consumption accessories.

**Financials**

High Tide currently has a market cap of around $400MM. Their revenue increased by 166% to $83M and gross profit increased by 112% to $8.7M for the year ended on Oct‚Äô20. This is not including any contribution from their merger with Meta Growth. The company overall is still in a loss as expected for a high growth startup with a net loss of $5M for the year ended on Oct‚Äô20 (compared to $21M loss in 2019).

Their revenue stream as expected is heavily biased towards Canada (82%), with the US contributing 18% and the rest of 1% coming from international markets. Over 50% of the retail revenue for the company came from their Cabana Club members (High Tide‚Äôs membership/loyalty program)

The company has a strong cash position of $38M as of Mar‚Äô21 which will give them a long runway to execute its growth plans. Their expected revenue for Q1‚Äô21 is $37-38M.

**Potential and Hype Factors**

**Store Expansion:** The company is investing heavily into store expansion and expects to have more than 115 stores by the end of 2021 which should significantly drive revenue growth and margin expansion.

**Increasing Cannabis Consumption:** Canada has witnessed an explosive growth in retail sales of adult recreation cannabis. The retail sales increased from $125M in October 2019 to $270M today, \~110% increase YoY.

**Nasdaq Listing:** The company has submitted its application to list on the Nasdaq stock market which would significantly add to the liquidity of the stock and also enable trading the stock in major platforms.

**Further deregulation/legalization in USA:** Any further deregulation or legalization of cannabis in USA would be extremely beneficial to High Tide as they are the largest player in Canada and can effectively leverage their existing position.

**Risk and Competition**

Currently, the biggest risk to High Tide is the barrier to entry within different Canadian provinces. Each Canadian province has a different system for cannabis distribution. For example, the largest market Ontario is currently issuing 30 new licenses per week with no upper limit. There is a possibility that the markets can become overcrowded and the existing margins can erode.

Another risk factor to consider is capital expenditure. High Tide needs to acquire prime real estate for their stores and the company would require continued access to capital to execute their ambitious store expansion strategy. Their competitor Fire & Flower has also announced a significant expansion in the Ontario market. All of this would drive up the High Tide‚Äôs capital expense and can significantly affect their margins.

**Conclusion**

The global legal marijuana market is currently valued at $24.6B and is expected to grow at a CAGR of 14%. Even though there are significant risks in terms of competition from Fire&Flower and Canada‚Äôs licensing system for Cannabis, High Tide currently being the market leader in the Canadian Cannabis industry is poised perfectly to capture the market in the long term and this puts them in a very strong position.

*Disclaimer: I am not a financial advisor.*",nobjos,10,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gslfv1t/,0.04,0.865,0.096,0.9861
53,FAF," I'm bullish on high tide, but I'm always appreciative of legitimately thought out bear cases.

I dont disagree on the pricing in the next couple months, but I anticipate news of nasdaq uplisting soon will change that significantly. I dont see how this aspect is any better with FAF, considering their consistent downtrend at the moment. I'd say trading semi sideways with a consistent uptrend despite recent market panics is more promising. I'm aware FAF is also pursuing uplisting, but I'm not sure of their timeframe

Where are you getting the data on negative revenue from high tide's retail locations?

I also think you're overlooking HITIs ecommerce business through grasscity and smokecartel, which individually are the largest in the industry. I dont see FAFs Hifyre being competitive in any way.

I read up a bit on the FAF circle k partnership, but I'm not truly convinced of the value here. Best I see is the location market research already done by circle k slightly increasing traffic per new FAF retail location. Otherwise, the businesses are completely separate, circle k is not selling FAF products at their existing locations afaik.",MistrDarp,2,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsle68h/,0.065,0.793,0.142,0.9523
54,FAF," I'm mostly just upset I didn't get in on it sooner, as for the revenue negative stores, I could have sworn I read an article but can't seem to find it now so I must be mistaken on that.

I do think the runup from 0.25 to 0.80 is speculative and based on perceived future value rather than present fundamentals.
This of course happened with most weed stocks when the US announced intent to legalize federally, but HITI appears to have held onto more of those gains than any of the others.

I do expect it to be worth a couple dollars in a few years, but a big dip at some point before that. I'm hoping to be able to buy in at 0.6 or less

> circle k is not selling FAF products at their existing locations afaik.

They're testing out a program where they put FAF stores next to existing Circle K's, and I'm interested to see if there's a substantial increase of foot traffic for those stores compared to standalone FAF locations.",Asheam,1,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsls7lt/,0.043,0.832,0.126,0.9343
55,ABC, 1 ABC,moosewhippets,2,/r/pennystocks/comments/mf10l4/most_discussed_stocks_in_pennystocks_last_week/gsl72qv/,0.0,1.0,0.0,0.0
56,TXMD, I have TXMD and I‚Äôm like -65% on it.. it‚Äôll make it sometime.. hopefully this year lol and preferably before June because I have calls on the lineüò≠,Howtosurviveanything,4,/r/pennystocks/comments/mep5zq/was_thinking_about_averaging_down_on_txmd_asked/gsj36o7/,0.0,0.742,0.258,0.7906
57,AMTX," Honestly u/trevandezz I owe you so much.

I was in Mara at 0.90 and consistently traded it since August

I was in XSPA in the summer and that got me 300% return

AMTX you really introduced me to it and I have traded it consistently, but did not hold like op did.

I've followed most of your picks and it worked out well mostly. Great dd and technical analysis.
Legend of this sub",UnknownXavier,3,/r/pennystocks/comments/meuhf2/amtx_gains/gslvdeb/,0.034,0.834,0.132,0.8241
58,XSPA," Honestly u/trevandezz I owe you so much.

I was in Mara at 0.90 and consistently traded it since August

I was in XSPA in the summer and that got me 300% return

AMTX you really introduced me to it and I have traded it consistently, but did not hold like op did.

I've followed most of your picks and it worked out well mostly. Great dd and technical analysis.
Legend of this sub",UnknownXavier,3,/r/pennystocks/comments/meuhf2/amtx_gains/gslvdeb/,0.034,0.834,0.132,0.8241
59,DD," Damn that‚Äôs tight, how long of a hold was this? And what was the prediction or DD that made u buy and hold all the way to $23",K-Dog18,2,/r/pennystocks/comments/meuhf2/amtx_gains/gsl0a7h/,0.097,0.903,0.0,-0.4019
60,PI," I think it‚Äôs a bit of both. Lithium market is soft right now. Seems like it ran a bit too hot in late ‚Äò20/ early ‚Äò21 and profits have been taken and rotated elsewhere, but eventually things will cycle back. In the interim I think the market sentiment is being exacerbated by some abnormally high short volume/open positions in Cyp. Over the last couple months we‚Äôve seen anywhere from 15-30% of daily volume come from short trades and the outstanding short positions continue to increase. I think some of the shorting is from PI Financial - sounds a bit greasy because they did the bought deal but it‚Äôs actually fairly normal - google ‚Äúgreenshoe options‚Äù and you‚Äôll see they use these over-allotment options to anchor the price a bit. But I think things have gotten a bit away from them and some other parties have jumped in and taken it further. My thinking is they wanted to get into the bought deal but couldn‚Äôt. Remember the financing oversubscribed the same day it was announced (A lot of interest in investing) but not everyone got in because cypress didn‚Äôt want to raise more money than they needed (they run a lean operation), so I suspect some investors with deep pockets were left on the sidelines. If you were left out and the stock is illiquid and can be manipulated easily why wouldn‚Äôt you (and maybe some of your buddies) go out and coordinate a short attack to reduce the price so you can get in for cheap and not pay a premium to everyone else? Of course this is all my theory, I can‚Äôt tell who is shorting but it‚Äôs being shorted!",GucciEngineer,1,/r/pennystocks/comments/meqcqt/lithium_miner_cypress_development_corp_update_pt3/gskvha1/,0.039,0.871,0.09,0.9125
61,MS," Low effort on $BCLI might do a longer write up,
Basically they just had massive results from their MS phase 2 completely unprecedented, if your gambling man any call after June when phase 3 is done, or for safe long term buy up shares while their low or LEAPS.
Nurown has already been proven to be safe so with actual clinical improvements this is huge and will surely blow the stock up within the next year and could be any day.",Environmental-Ad1748,2,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsknlpm/,0.047,0.78,0.173,0.8834
62,FOR," BETS (OTC:BLITF) is the real deal! Just announced an 8 year multi-BILLION dollar deal with a US and worldwide-facing partner. They‚Äôre under NDA currently and can‚Äôt name the partner but this thing is going to explode. CEO knows he has a cash machine, doesn‚Äôt take a salary, and is going to run this stock price as high as possible to sell the company in 24-36 months. Looking at an easy 15X short term, but his minimum to sell is $10/share. I think he‚Äôll be selling for a lot more than that. Growth and attention with this deal which involves 30-40% revenue sharing with casinos, at NO COST FOR US ENTRY, is going to send this thing rocketing when they‚Äôre allowed to formally announce... check out the the latest WSR for all the details. I have bought in quite a bit. 

[WSR BLITF revealing monster deal for US entry](https://youtu.be/69TPqaoGOU8)",Eastsg,2,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gskwe2q/,0.026,0.897,0.077,0.8289
63,WSR," BETS (OTC:BLITF) is the real deal! Just announced an 8 year multi-BILLION dollar deal with a US and worldwide-facing partner. They‚Äôre under NDA currently and can‚Äôt name the partner but this thing is going to explode. CEO knows he has a cash machine, doesn‚Äôt take a salary, and is going to run this stock price as high as possible to sell the company in 24-36 months. Looking at an easy 15X short term, but his minimum to sell is $10/share. I think he‚Äôll be selling for a lot more than that. Growth and attention with this deal which involves 30-40% revenue sharing with casinos, at NO COST FOR US ENTRY, is going to send this thing rocketing when they‚Äôre allowed to formally announce... check out the the latest WSR for all the details. I have bought in quite a bit. 

[WSR BLITF revealing monster deal for US entry](https://youtu.be/69TPqaoGOU8)",Eastsg,2,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gskwe2q/,0.026,0.897,0.077,0.8289
64,AOS, I like AOS.,tkon403,1,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsjohg5/,0.0,0.286,0.714,0.3612
65,ACER," Hello all,

To preface if you check my post history you can see I'm heavily invested in this ($33,816.15) to be exact - obligatory not a financial advisor/nor is this advice and do your own research Yada Yada. Just to be upfront and you can begin critical of what I have to say knowing my position. I am also writing this on my phone so apologies in advance for format - I'll try to add links later in edits 

So rlftf - ran in August up to 96 cents off the initial hype for its drug Zyesami (was called rlf-100). Has been bumpy since then. I will cover a variety of recent events after providing some basic information about the drug and company. 

Drug:
-covid treatment with 2 major trials currently running in stage 2b/3
-has shown in open label studies earlier on increase survival rate and reduce respiratory failure 
-28 day data which was released on Feb 9 showed statistically significant 10 day shorter hospital time compared to standard of care treatment. 
-now you'll see a massive falloff in stock price here - this is because survival improvement wasn't statistically significant. In the open label study which had approx 40 people the survival rate wasn't shown to improve at 28 days either - it only appeared at 60 day results. These early findings were reported in November. 

The reason being is that a lot of people relapse and become sick again and in my judgement the Feb 9 drop occurred to a lack of understanding that at 28 days survival rate should not have been expected to improve.

The drug had been tested in the past for erectile dysfunction - which at  face value who cares right? Well that means all the safety data in the world has already been gathered for this drug and the FDAs primary focus when issuing EUAs is 1. May be effective 2. Safety 3. Does not cause the virus to mutate 

1. Ten day confirmed shorter hospital stay which is needed to clear out overburdened ICU's and saves patients for 100k on average in bills. 
2. This is an old drug that mimics a peptide made in our body and is extremely safe with zero severe side effects 
3. Being a peptide this is not a concern - mutation concerns are usually related to anti-virals 

The lead investigator - J. Javitt has brought 7 drugs to FDA approval in his career and has studied at Harvard and led many bio start-ups in the past. 

The company - rlftf currently is trading @.29 and has a total share count of 3.4 billion approximately. Yes - that's a lot of shares and is a negative, but their current market cap sits at 985m. To compare Cydy, another covid play - market cap was sitting at 4.4billion until poor results came in from their trial. 

There are currently no approved therapeutics to treat SEVERE conditioned patients and this could potentially be the first. 

With that in mind you may ask - well vaccines are here covid isn't going to stick around so what's this worth? 

1. The US may be on its way to being mostly vaccinated, but many other countries haven't begun giving out a single vaccine yet. 
2. Google how many people do not plan on getting vaccinated - recent surveys in feb/march show anywhere from 22 percent to 51 percent are not sure, will wait, or will not get it
3. Variants are spreading and there's a lot of them which means more will come. 

Company is expanding:
Rlftf has recently announced that they have manufacturing agreements with ACER, a new formulation for their inhaler study with TFF, and the company neurorx that they are working on the drug with recently agreed with BRPA to come to market via an SPAC. These are all signs that their is a strong belief that this drug works. 


 The 60 day results are being unblinded tomorrow at 8:30 EDT for the intravenous trial for severe condition covid patients. This is the big catalyst -if results are good FDA approval should be a given which would make this the first approved therapeutic for severe covid patients and news outlets should pick up on this.

After that the inhaler trial which is already started as of March 19th for moderate/severe patients is a 28 day study which if the intravenous study is approved this will likely be as well as will have much wider usage - this is the money maker and it is also being studied for other ARDS diseases as well. 

J. Javitt already hinted on his LinkedIn that he has a meeting with the FDA coming up and I expect big things from this company in the next few months starting this week. 



Tldr:
-Covid treatment study results tomorrow at market open for phase 2b/3
-if good FDA meeting/approval within a month
-first to be approved for severe condition patients and will get media attention 
-attractive treatment as there are no safety concerns /lower side effects compared to other drugs currently available 
-will set up inhaler trial for success in covid and other lung conditions 
-company has been expanding rapidly with many new partnerships signaling positive outlook",Puzzleheaded_Fan_123,1,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsldfdh/,0.052,0.837,0.111,0.9945
66,ARDS," Hello all,

To preface if you check my post history you can see I'm heavily invested in this ($33,816.15) to be exact - obligatory not a financial advisor/nor is this advice and do your own research Yada Yada. Just to be upfront and you can begin critical of what I have to say knowing my position. I am also writing this on my phone so apologies in advance for format - I'll try to add links later in edits 

So rlftf - ran in August up to 96 cents off the initial hype for its drug Zyesami (was called rlf-100). Has been bumpy since then. I will cover a variety of recent events after providing some basic information about the drug and company. 

Drug:
-covid treatment with 2 major trials currently running in stage 2b/3
-has shown in open label studies earlier on increase survival rate and reduce respiratory failure 
-28 day data which was released on Feb 9 showed statistically significant 10 day shorter hospital time compared to standard of care treatment. 
-now you'll see a massive falloff in stock price here - this is because survival improvement wasn't statistically significant. In the open label study which had approx 40 people the survival rate wasn't shown to improve at 28 days either - it only appeared at 60 day results. These early findings were reported in November. 

The reason being is that a lot of people relapse and become sick again and in my judgement the Feb 9 drop occurred to a lack of understanding that at 28 days survival rate should not have been expected to improve.

The drug had been tested in the past for erectile dysfunction - which at  face value who cares right? Well that means all the safety data in the world has already been gathered for this drug and the FDAs primary focus when issuing EUAs is 1. May be effective 2. Safety 3. Does not cause the virus to mutate 

1. Ten day confirmed shorter hospital stay which is needed to clear out overburdened ICU's and saves patients for 100k on average in bills. 
2. This is an old drug that mimics a peptide made in our body and is extremely safe with zero severe side effects 
3. Being a peptide this is not a concern - mutation concerns are usually related to anti-virals 

The lead investigator - J. Javitt has brought 7 drugs to FDA approval in his career and has studied at Harvard and led many bio start-ups in the past. 

The company - rlftf currently is trading @.29 and has a total share count of 3.4 billion approximately. Yes - that's a lot of shares and is a negative, but their current market cap sits at 985m. To compare Cydy, another covid play - market cap was sitting at 4.4billion until poor results came in from their trial. 

There are currently no approved therapeutics to treat SEVERE conditioned patients and this could potentially be the first. 

With that in mind you may ask - well vaccines are here covid isn't going to stick around so what's this worth? 

1. The US may be on its way to being mostly vaccinated, but many other countries haven't begun giving out a single vaccine yet. 
2. Google how many people do not plan on getting vaccinated - recent surveys in feb/march show anywhere from 22 percent to 51 percent are not sure, will wait, or will not get it
3. Variants are spreading and there's a lot of them which means more will come. 

Company is expanding:
Rlftf has recently announced that they have manufacturing agreements with ACER, a new formulation for their inhaler study with TFF, and the company neurorx that they are working on the drug with recently agreed with BRPA to come to market via an SPAC. These are all signs that their is a strong belief that this drug works. 


 The 60 day results are being unblinded tomorrow at 8:30 EDT for the intravenous trial for severe condition covid patients. This is the big catalyst -if results are good FDA approval should be a given which would make this the first approved therapeutic for severe covid patients and news outlets should pick up on this.

After that the inhaler trial which is already started as of March 19th for moderate/severe patients is a 28 day study which if the intravenous study is approved this will likely be as well as will have much wider usage - this is the money maker and it is also being studied for other ARDS diseases as well. 

J. Javitt already hinted on his LinkedIn that he has a meeting with the FDA coming up and I expect big things from this company in the next few months starting this week. 



Tldr:
-Covid treatment study results tomorrow at market open for phase 2b/3
-if good FDA meeting/approval within a month
-first to be approved for severe condition patients and will get media attention 
-attractive treatment as there are no safety concerns /lower side effects compared to other drugs currently available 
-will set up inhaler trial for success in covid and other lung conditions 
-company has been expanding rapidly with many new partnerships signaling positive outlook",Puzzleheaded_Fan_123,1,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsldfdh/,0.052,0.837,0.111,0.9945
67,BRPA," Hello all,

To preface if you check my post history you can see I'm heavily invested in this ($33,816.15) to be exact - obligatory not a financial advisor/nor is this advice and do your own research Yada Yada. Just to be upfront and you can begin critical of what I have to say knowing my position. I am also writing this on my phone so apologies in advance for format - I'll try to add links later in edits 

So rlftf - ran in August up to 96 cents off the initial hype for its drug Zyesami (was called rlf-100). Has been bumpy since then. I will cover a variety of recent events after providing some basic information about the drug and company. 

Drug:
-covid treatment with 2 major trials currently running in stage 2b/3
-has shown in open label studies earlier on increase survival rate and reduce respiratory failure 
-28 day data which was released on Feb 9 showed statistically significant 10 day shorter hospital time compared to standard of care treatment. 
-now you'll see a massive falloff in stock price here - this is because survival improvement wasn't statistically significant. In the open label study which had approx 40 people the survival rate wasn't shown to improve at 28 days either - it only appeared at 60 day results. These early findings were reported in November. 

The reason being is that a lot of people relapse and become sick again and in my judgement the Feb 9 drop occurred to a lack of understanding that at 28 days survival rate should not have been expected to improve.

The drug had been tested in the past for erectile dysfunction - which at  face value who cares right? Well that means all the safety data in the world has already been gathered for this drug and the FDAs primary focus when issuing EUAs is 1. May be effective 2. Safety 3. Does not cause the virus to mutate 

1. Ten day confirmed shorter hospital stay which is needed to clear out overburdened ICU's and saves patients for 100k on average in bills. 
2. This is an old drug that mimics a peptide made in our body and is extremely safe with zero severe side effects 
3. Being a peptide this is not a concern - mutation concerns are usually related to anti-virals 

The lead investigator - J. Javitt has brought 7 drugs to FDA approval in his career and has studied at Harvard and led many bio start-ups in the past. 

The company - rlftf currently is trading @.29 and has a total share count of 3.4 billion approximately. Yes - that's a lot of shares and is a negative, but their current market cap sits at 985m. To compare Cydy, another covid play - market cap was sitting at 4.4billion until poor results came in from their trial. 

There are currently no approved therapeutics to treat SEVERE conditioned patients and this could potentially be the first. 

With that in mind you may ask - well vaccines are here covid isn't going to stick around so what's this worth? 

1. The US may be on its way to being mostly vaccinated, but many other countries haven't begun giving out a single vaccine yet. 
2. Google how many people do not plan on getting vaccinated - recent surveys in feb/march show anywhere from 22 percent to 51 percent are not sure, will wait, or will not get it
3. Variants are spreading and there's a lot of them which means more will come. 

Company is expanding:
Rlftf has recently announced that they have manufacturing agreements with ACER, a new formulation for their inhaler study with TFF, and the company neurorx that they are working on the drug with recently agreed with BRPA to come to market via an SPAC. These are all signs that their is a strong belief that this drug works. 


 The 60 day results are being unblinded tomorrow at 8:30 EDT for the intravenous trial for severe condition covid patients. This is the big catalyst -if results are good FDA approval should be a given which would make this the first approved therapeutic for severe covid patients and news outlets should pick up on this.

After that the inhaler trial which is already started as of March 19th for moderate/severe patients is a 28 day study which if the intravenous study is approved this will likely be as well as will have much wider usage - this is the money maker and it is also being studied for other ARDS diseases as well. 

J. Javitt already hinted on his LinkedIn that he has a meeting with the FDA coming up and I expect big things from this company in the next few months starting this week. 



Tldr:
-Covid treatment study results tomorrow at market open for phase 2b/3
-if good FDA meeting/approval within a month
-first to be approved for severe condition patients and will get media attention 
-attractive treatment as there are no safety concerns /lower side effects compared to other drugs currently available 
-will set up inhaler trial for success in covid and other lung conditions 
-company has been expanding rapidly with many new partnerships signaling positive outlook",Puzzleheaded_Fan_123,1,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsldfdh/,0.052,0.837,0.111,0.9945
68,CB," FWIW, I sold out around $1.10/ share with a CB of .52. I‚Äôd doubled and wanted off the ride. It went down but hasn‚Äôt crashed so maybe some long term growth possible. For me, after getting started with pennies, and most crashing, I decided to cash out any that doubled. Good luck!",BacklogBeast,3,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsk55s6/,0.0,0.774,0.226,0.9208
69,DD," Mostly it's basic financial data, like cashflow, debt, revenue, and so on. Not all companies have fundamentals, though - I'm currently trying to write my first DD on a company that has zero cashflow so far. It's on the market, it looks promising, but I'll be honest, financials make the analysis way easier.",lunarladyps,3,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gslbdb9/,0.029,0.773,0.197,0.875
70,FNKO, I have PONGF + TRWRF + FNKO + FDMSF + TAPM + CINGF. Might buy more PONGF,NPRjunkieDC,1,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsm1q8h/,0.0,1.0,0.0,0.0
71,DD," I'm considering this, and going to DD hard today so please don't be another pumper, my heart could not take this. You seem trustworthy and rocket emoji-less enough to take seriously, and I need a good ""bets""/gambling based stock.",Service-Fickle,5,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gsli5wd/,0.07,0.724,0.206,0.7902
72,TDA, Think or swim TDA commission $6.95 plus $2.95 foreign transaction fee I was told etrade also has EEENF for only the commission,HulkSmash-1967,3,/r/pennystocks/comments/meting/the_lounge_thoughts_noob_stuff_low_effort_brokers/gslf0kj/,0.0,1.0,0.0,0.0
73,DD," I think any DD on a Chinese company, or company jumping into business in China should mention the current political events. Things are dangerous for investors right now in that area.",PTSDefiant,8,/r/pennystocks/comments/mf7ga6/mict_the_future_chinese_trading_platformapp/gslzbom/,0.1,0.9,0.0,-0.4767
74,NAV, The thing about NPA is that I doubt the share price will crash too much its almost NAV right now. If u really think their gonna execute on all the shit they have planned then investing now is your best bet. they have a reasonable chance of being a 100-bagger its just a lot of speculation on if everything works out as planned,Pleasant_Swim7443,1,/r/pennystocks/comments/metlmr/play_the_catalysts_and_the_growth_value_ramp_up/gsjs54r/,0.075,0.747,0.178,0.802
75,NPA, The thing about NPA is that I doubt the share price will crash too much its almost NAV right now. If u really think their gonna execute on all the shit they have planned then investing now is your best bet. they have a reasonable chance of being a 100-bagger its just a lot of speculation on if everything works out as planned,Pleasant_Swim7443,1,/r/pennystocks/comments/metlmr/play_the_catalysts_and_the_growth_value_ramp_up/gsjs54r/,0.075,0.747,0.178,0.802
